FDA Approved: ORIAHNN — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved ORIAHNN, a fixed-dose combination of elagolix, estradiol, and norethindrone, from AbbVie in an Original Application, for the treatment of uterine f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• ORIAHNN (ELAGOLIX AND ESTRADIOL AND NORETHISTERONE)

Snippet

ORIG AP for ORIAHNN (ELAGOLIX AND ESTRADIOL AND NORETHISTERONE)